Desh Rakshak

{
  "main_header": {
    "sid": 351394,
    "name": "Desh Rakshak",
    "stock_name": "Desh Rakshak",
    "full_name": "Desh Rakshak Aushdhalaya Ltd",
    "name_url": "stocks-analysis/desh-rakshak",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "31.00",
    "mcapval": "18.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531521,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE971E01016",
    "curr_date": "Jul 17, 03:30 PM",
    "curr_time": "04:48 AM",
    "last_traded_at": "Jul 17, 03:30 PM IST",
    "bse_nse_vol": "100 ",
    "exc_status": "Active",
    "traded_date": "Jul 17, 2026",
    "traded_date_str": "2026 07 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/desh-rakshak-351394-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shifts-signal-renewed-price-attractiveness-4104296",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DeshRakshakAush_valuationdot_4104296.png",
        "date": "2026-07-16 08:00:14",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade. Despite recent share price declines, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling case relative to its historical averages and peer group, prompting a reassessment of its price attractiveness amid ongoing sector volatility."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Falls 2.00%: Technical Weakness and Valuation Shift Define Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-falls-200-technical-weakness-and-valuation-shift-define-week-4075638",
        "imagepath": "",
        "date": "2026-06-27 17:12:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>22 Jun:</strong> Stock opened steady at Rs.35.00 with no price change</p>\n                    <p><strong>23 Jun:</strong> Price remained flat at Rs.35.00 despite Sensex decline</p>\n                    <p><strong>24 Jun:</strong> Stock declined 2.00% to Rs.34.30 amid technical concerns</p>\n                    <p><strong>25 Jun:</strong> Downgrade to Strong Sell and valuation shift reported</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.35.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-va..."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Downgraded to Strong Sell Amid Technical and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/desh-rakshak-aushdhalaya-ltd-downgraded-to-strong-sell-amid-technical-and-financial-concerns-4072647",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DeshRakshakAush_mojoScore_4072647.png",
        "date": "2026-06-25 08:29:19",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 24 June 2026. This shift reflects a complex interplay of deteriorating technical indicators, modest valuation improvements, stagnant financial trends, and an overall weak quality assessment. Investors should carefully consider these factors amid the company’s subdued market performance and challenging fundamentals."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shifts-signal-changing-market-sentiment-4072317",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DeshRakshakAush_valuationdot_4072317.png",
        "date": "2026-06-25 08:00:21",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a risky to a fair valuation grade. This change reflects evolving market perceptions amid a backdrop of mixed financial metrics and sector comparisons, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks."
      },
      {
        "title": "Are Desh Rakshak Aushdhalaya Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-desh-rakshak-aushdhalaya-ltd-latest-results-good-or-bad-4023976",
        "imagepath": "",
        "date": "2026-05-30 19:55:29",
        "description": "Desh Rakshak Aushdhalaya Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape characterized by significant sequential recovery in profitability but persistent challenges in revenue generation. The company reported a net profit of ₹0.30 crores, reflecting a notable sequential increase of 233.33% from the previous quarter. This improvement in net profit was accompanied by a substantial quarter-on-quarter revenue growth of 146.43%, rising to ₹3.45 crores from ₹1.40 crores in Q3 FY26.\n\nHowever, the year-on-year comparison highlights a decline in revenue, with a decrease of 21.41% from ₹4.39 crores in Q4 FY25. This trend raises concerns about ongoing demand challenges within the company's core Ayurvedic product portfolio. Despite the revenue volatility, Desh Rakshak demonstrated effective cost management, as evidenced by an operating margin of 17.97%, which improved from 15.43% in th..."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Gains 10.65%: Key Valuation and Technical Shifts Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-gains-1065-key-valuation-and-technical-shifts-drive-momentum-4023616",
        "imagepath": "",
        "date": "2026-05-30 17:19:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Stock opens at ₹33.21, surging 5.00%</p>\n                    <p><strong>26 May:</strong> Further 5.00% gain following upgrade announcement</p>\n                    <p><strong>27 May:</strong> Price peaks at ₹36.61 (+4.99%) amid rating upgrade</p>\n                    <p><strong>29 May:</strong> Price retreats 4.40% to close week at ₹35.00</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹31.63</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹35.00</div><div class=\"stat-chan..."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Q4 FY26: Profitability Rebounds Sharply But Revenue Decline Persists",
        "link": "https://www.marketsmojo.com/news/result-analysis/desh-rakshak-aushdhalaya-q4-fy26-profitability-rebounds-sharply-but-revenue-decline-persists-4022954",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeshRakshakAush_quaterlyResult_4022954.png",
        "date": "2026-05-29 22:32:49",
        "description": "Desh Rakshak Aushdhalaya Ltd., one of India's oldest manufacturers of pure Ayurvedic and herbal products, reported a mixed performance for the quarter ended March 2026, with net profit surging 233.33% quarter-on-quarter to ₹0.30 crores, yet revenue continuing to decline year-on-year by 21.41%. The micro-cap pharmaceutical company, with a market capitalisation of ₹21.00 crores, saw its stock tumble 4.40% to ₹35.00 following the results announcement, reflecting investor concerns about sustained revenue weakness despite improved profitability."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shifts-signal-changing-market-sentiment-4019185",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeshRakshakAush_valuationdot_4019185.png",
        "date": "2026-05-29 08:00:48",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift from attractive to fair, reflecting a nuanced change in market perception. Despite a recent 4.99% rise in share price to ₹36.61, the company’s price-to-earnings (P/E) ratio now stands at 33.11, signalling a more tempered valuation compared to its historical and peer averages."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Upgraded to Sell on Technical and Valuation Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/desh-rakshak-aushdhalaya-ltd-upgraded-to-sell-on-technical-and-valuation-improvements-4017796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeshRakshakAush_mojoScore_4017796.png",
        "date": "2026-05-28 08:27:56",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 27 May 2026. This change reflects a nuanced improvement across technical indicators and valuation metrics, despite ongoing challenges in financial performance and long-term fundamentals."
      }
    ],
    "total": 227,
    "sid": "351394",
    "stock_news_url": "https://www.marketsmojo.com/news/desh-rakshak-aushdhalaya-351394"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Jul-2026",
      "details": "The Company enclosed Confirmation Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 issued by M/s. Nivis Corpserve LLP Registrar and Share Transfer Agent of the Company",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Jun-2026",
      "details": "Intimation for closure of trading window for all the designated persons designated employees specified persons connected persons insiders and their immediative relatives pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in RTA",
      "datetime": "23-Jun-2026",
      "details": "Intimation for tripartite agreement between the Company Old RTA and New RTA under Regulation 7 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-07-16 08:00:14

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade. Despite recent share price declines, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling case relative to its historical averages and peer group, prompting a reassessment of its price attractiveness amid ongoing sector volatility.

Read full news article

Desh Rakshak Aushdhalaya Ltd Falls 2.00%: Technical Weakness and Valuation Shift Define Week

2026-06-27 17:12:17

Key Events This Week

22 Jun: Stock opened steady at Rs.35.00 with no price change

23 Jun: Price remained flat at Rs.35.00 despite Sensex decline

24 Jun: Stock declined 2.00% to Rs.34.30 amid technical concerns

25 Jun: Downgrade to Strong Sell and valuation shift reported

Week Open

Rs.35.00

Week Close

Read full news article

Desh Rakshak Aushdhalaya Ltd Downgraded to Strong Sell Amid Technical and Financial Concerns

2026-06-25 08:29:19

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 24 June 2026. This shift reflects a complex interplay of deteriorating technical indicators, modest valuation improvements, stagnant financial trends, and an overall weak quality assessment. Investors should carefully consider these factors amid the company’s subdued market performance and challenging fundamentals.

Read full news article

Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Changing Market Sentiment

2026-06-25 08:00:21

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a risky to a fair valuation grade. This change reflects evolving market perceptions amid a backdrop of mixed financial metrics and sector comparisons, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks.

Read full news article

Are Desh Rakshak Aushdhalaya Ltd latest results good or bad?

2026-05-30 19:55:29

Desh Rakshak Aushdhalaya Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape characterized by significant sequential recovery in profitability but persistent challenges in revenue generation. The company reported a net profit of ₹0.30 crores, reflecting a notable sequential increase of 233.33% from the previous quarter. This improvement in net profit was accompanied by a substantial quarter-on-quarter revenue growth of 146.43%, rising to ₹3.45 crores from ₹1.40 crores in Q3 FY26. However, the year-on-year comparison highlights a decline in revenue, with a decrease of 21.41% from ₹4.39 crores in Q4 FY25. This trend raises concerns about ongoing demand challenges within the company's core Ayurvedic product portfolio. Despite the revenue volatility, Desh Rakshak demonstrated effective cost management, as evidenced by an operating margin of 17.97%, which improved from 15.43% in th...

Read full news article

Desh Rakshak Aushdhalaya Ltd Gains 10.65%: Key Valuation and Technical Shifts Drive Momentum

2026-05-30 17:19:53

Key Events This Week

25 May: Stock opens at ₹33.21, surging 5.00%

26 May: Further 5.00% gain following upgrade announcement

27 May: Price peaks at ₹36.61 (+4.99%) amid rating upgrade

29 May: Price retreats 4.40% to close week at ₹35.00

Week Open

₹31.63

Week Close

₹35.00

Read full news article

Desh Rakshak Aushdhalaya Q4 FY26: Profitability Rebounds Sharply But Revenue Decline Persists

2026-05-29 22:32:49

Desh Rakshak Aushdhalaya Ltd., one of India's oldest manufacturers of pure Ayurvedic and herbal products, reported a mixed performance for the quarter ended March 2026, with net profit surging 233.33% quarter-on-quarter to ₹0.30 crores, yet revenue continuing to decline year-on-year by 21.41%. The micro-cap pharmaceutical company, with a market capitalisation of ₹21.00 crores, saw its stock tumble 4.40% to ₹35.00 following the results announcement, reflecting investor concerns about sustained revenue weakness despite improved profitability.

Read full news article

Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Changing Market Sentiment

2026-05-29 08:00:48

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift from attractive to fair, reflecting a nuanced change in market perception. Despite a recent 4.99% rise in share price to ₹36.61, the company’s price-to-earnings (P/E) ratio now stands at 33.11, signalling a more tempered valuation compared to its historical and peer averages.

Read full news article

Desh Rakshak Aushdhalaya Ltd Upgraded to Sell on Technical and Valuation Improvements

2026-05-28 08:27:56

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 27 May 2026. This change reflects a nuanced improvement across technical indicators and valuation metrics, despite ongoing challenges in financial performance and long-term fundamentals.

Read full news article

View All News